Investors will find a few items of interest in Saturday’s quarterly report from Warren Buffett’s conglomerate.

Shares of TG Therapeutics slumped after the company's second-quarter profit missed analyst estimates. The stock was down 17% at $29.22 in early trading. Shares are now 3% lower than where they had ...

Nonetheless, Zoom is still the leading online meeting platform. Also, even though the stock trades at a small fraction of its ...

Marsh & McLennan has increased its dividend for 16 consecutive years. Its 10-year dividend growth rate is an impressive 11.1% ...

This article will be updated throughout the day, so check back often for more daily updates. Last week ended on a down note — and a 2.4% weekly loss for the Vanguard S&P 500 ETF (NYSEMKT: VOO) — as a ...

CVS’s stock was having its best day in more than five months, amid strong growth in all of the company’s business units.

Then there’s the broader macro. If volatility spikes post-Fed or if markets sell off into August, a crowded long in MP could ...

Shares of beer, wine, and liquor companies including AB InBev are having a rough time as many consumers have cut back on ...

For the first quarter ended June 30, 2025, Tata Investment Corp posted a 11.6% year-on-year (YoY) rise in consolidated profit ...

Aditya Birla Capital posted a 10% YoY rise in net profit and strong growth across lending, insurance, and asset management ...

MCX shares rose over 5% following an 83% increase in net profit for the June quarter, reaching Rs 203.19 crore. Revenue grew ...

Aug 2 (Reuters) - Warren Buffett's Berkshire Hathaway (BRKa.N) said on Saturday it took a $3.76 billion write-down on its ...